Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for RBSH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2008. Start Trial.
Date Value
June 30, 2023 0.009M
March 31, 2023 0.005M
December 31, 2022 0.005M
September 30, 2022 0.134M
June 30, 2022 0.265M
March 31, 2022 0.589M
December 31, 2021 0.715M
September 30, 2021 0.995M
June 30, 2021 1.13M
March 31, 2021 0.758M
December 31, 2020 0.404M
September 30, 2020 0.033M
June 30, 2020 0.116M
March 31, 2020 0.146M
December 31, 2019 0.023M
September 30, 2019 0.07M
June 30, 2019 0.255M
March 31, 2019 0.307M
December 31, 2018 0.366M
September 30, 2018 0.389M
June 30, 2018 0.049M
March 31, 2018 0.057M
December 31, 2017 0.069M
September 30, 2017 2.60M
June 30, 2017 0.105M
Date Value
March 31, 2017 0.247M
December 31, 2016 0.734M
September 30, 2016 0.54M
June 30, 2016 1.083M
March 31, 2016 1.768M
December 31, 2015 2.678M
September 30, 2015 1.472M
June 30, 2015 0.312M
March 31, 2015 1.678M
December 31, 2014 2.629M
September 30, 2014 3.856M
June 30, 2014 5.091M
March 31, 2014 2.855M
December 31, 2013 3.885M
September 30, 2013 5.201M
June 30, 2013 1.841M
March 31, 2013 2.855M
December 31, 2012 2.573M
September 30, 2012 2.696M
June 30, 2012 4.099M
March 31, 2012 5.027M
December 31, 2011 5.691M
September 30, 2011 6.82M
June 30, 2011 8.211M
March 31, 2011 7.003M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 1.743B
Alnylam Pharmaceuticals, Inc. 5.559B
Anika Therapeutics, Inc. 183.47M
Savara, Inc. 192.14M
Vericel Corp. 502.87M